Characterization of CD44-Mediated Cancer Cell Uptake and Intracellular Distribution of Hyaluronan-Grafted Liposomes
- 22 June 2011
- journal article
- research article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 8 (4), 1233-1246
- https://doi.org/10.1021/mp2000428
Abstract
Hyaluronan (HA) is a biocompatible and biodegradable linear polysaccharide which is of interest for tumor targeting through cell surface CD44 receptors. HA binds with high affinity to CD44 receptors, which are overexpressed in many tumors and involved in cancer metastasis. In the present study, we investigated the impact of HA molecular weight (MW), grafting density, and CD44 receptor density on endocytosis of HA-grafted liposomes (HA–liposomes) by cancer cells. Additionally, the intracellular localization of the HA–liposomes was determined. HAs of different MWs (5–8, 10–12, 175–350, and 1600 kDa) were conjugated to liposomes with varying degrees of grafting density. HA surface density was quantified using the hexadecyltrimethylammonium bromide turbidimetric method. Cellular uptake and subcellular localization of HA–liposomes were evaluated by flow cytometry and fluorescence microscopy. Mean particle sizes of HA–liposomes ranged from 120 to 180 nm and increased with increasing size of HA. HA–liposome uptake correlated with HA MW (5–8 < 10–12 < 175–350 kDa), grafting density, and CD44 receptor density and exceeded that obtained with unconjugated plain liposomes. HA–liposomes were taken up into cells via lipid raft-mediated endocytosis, which is both energy- and cholesterol-dependent. Once within cells, HA–liposomes localized primarily to endosomes and lysosomes. The results demonstrate that cellular targeting efficiency of HA–liposomes depends strongly upon HA MW, grafting density, and cell surface receptor CD44 density. The results support a role of HA–liposomes for targeted drug delivery.Keywords
This publication has 68 references indexed in Scilit:
- Low Cholesterol Triggers Membrane Microdomain-dependent CD44 Shedding and Suppresses Tumor Cell MigrationPublished by Elsevier BV ,2011
- Analysis of CD44-Hyaluronan Interactions in an Artificial Membrane System: INSIGHTS INTO THE DISTINCT BINDING PROPERTIES OF HIGH AND LOW MOLECULAR WEIGHT HYALURONAN*Journal of Biological Chemistry, 2010
- Nanoconjugation modulates the trafficking and mechanism of antibody induced receptor endocytosisProceedings of the National Academy of Sciences of the United States of America, 2010
- Hyaluronan-CD44 Interactions in Cancer: Paradoxes and PossibilitiesClinical Cancer Research, 2009
- Intact extracellular matrix and the maintenance of immune tolerance: high molecular weight hyaluronan promotes persistence of induced CD4+CD25+ regulatory T cellsJournal of Leukocyte Biology, 2009
- An efficient and low immunostimulatory nanoparticle formulation for systemic siRNA delivery to the tumorJournal of Controlled Release, 2008
- CD44 Engagement Promotes Matrix-Derived Survival through the CD44-SRC-Integrin Axis in Lipid RaftsMolecular and Cellular Biology, 2008
- Anticancer Therapeutics: Targeting Macromolecules and Nanocarriers to Hyaluronan or CD44, a Hyaluronan ReceptorMolecular Pharmaceutics, 2008
- Systemic Leukocyte-Directed siRNA Delivery Revealing Cyclin D1 as an Anti-Inflammatory TargetScience, 2008
- Lipid Rafts, Detergent-Resistant Membranes, and Raft Targeting SignalsPhysiology, 2006